News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

RTI Biologics, ENTrigue Surgical, Inc. Announce Development and Supply Agreement For Tutoplast(R)-Processed Tissues



12/15/2008 11:28:51 AM

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics, Inc. (RTI) (Nasdaq:RTIX), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, announced today that it has signed an agreement to provide biologic implants to ENTrigue Surgical, Inc., the Texas-based manufacturer of medical devices and instrumentation for the surgical treatment of conditions of the ear, nose and throat (ENT).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES